MAPK3
Mitogen-activated protein kinase 3
Also known as: ERK1, MK03_HUMAN, p44erk1, p44mapk, PRKM3
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- P27361
- Gene
- MAPK3
- Ensembl
- ENSG00000102882
- Chromosome
- 16
- Canonical length
- 379 aa
- Protein class
- Cancer-related genes, Enzymes, FDA approved drug targets, Predicted intracellular proteins, RAS pathway related proteins
- Subcellular location
- Nucleoplasm,Microtubules,Primary cilium,Primary cilium tip,Basal body
OverviewNCBI Gene
The protein encoded by this gene is a member of the MAP kinase family. MAP kinases, also known as extracellular signal-regulated kinases (ERKs), act in a signaling cascade that regulates various cellular processes such as proliferation, differentiation, and cell cycle progression in response to a variety of extracellular signals. This kinase is activated by upstream kinases, resulting in its translocation to the nucleus where it phosphorylates nuclear targets. Alternatively spliced transcript variants encoding different protein isoforms have been described. [provided by RefSeq, Jul 2008]
Canonical amino-acid sequenceUniProt
379 residues, UniProt reviewed canonical sequence.
>P27361|MAPK3
1 MAAAAAQGGG GGEPRRTEGV GPGVPGEVEM VKGQPFDVGP RYTQLQYIGE GAYGMVSSAY
61 DHVRKTRVAI KKISPFEHQT YCQRTLREIQ ILLRFRHENV IGIRDILRAS TLEAMRDVYI
121 VQDLMETDLY KLLKSQQLSN DHICYFLYQI LRGLKYIHSA NVLHRDLKPS NLLINTTCDL
181 KICDFGLARI ADPEHDHTGF LTEYVATRWY RAPEIMLNSK GYTKSIDIWS VGCILAEMLS
241 NRPIFPGKHY LDQLNHILGI LGSPSQEDLN CIINMKARNY LQSLPSKTKV AWAKLFPKSD
301 SKALDLLDRM LTFNPNKRIT VEEALAHPYL EQYYDPTDEP VAEEPFTFAM ELDDLPKERL
361 KELIFQETAR FQPGVLEAPLocalizationUniProt · AlphaFold · HPA
Whether an antibody against MAPK3 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Cell surface
- Secreted
- No
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.27
- Highest tissue expression
- 233 nTPM
Expression across tissuesHPA
Tissue
- amygdala: 233 nTPM
- cerebral cortex: 223 nTPM
- basal ganglia: 154 nTPM
- hippocampal formation: 141 nTPM
- esophagus: 126 nTPM
- midbrain: 120 nTPM
Single-cell type
- esophageal apical cells: 543 nCPM
- early spermatids: 326 nCPM
- colonocytes: 269 nCPM
- late spermatids: 230 nCPM
- enterocytes: 226 nCPM
- goblet cells: 190 nCPM
Immune cell
- eosinophil: 49 nTPM
- neutrophil: 22 nTPM
- T-reg: 6.6 nTPM
- basophil: 6.3 nTPM
- classical monocyte: 5.1 nTPM
- intermediate monocyte: 3.7 nTPM
Brain region
- cerebral cortex: 250 nTPM
- amygdala: 248 nTPM
- basal ganglia: 211 nTPM
- midbrain: 191 nTPM
- pons: 177 nTPM
- hippocampal formation: 174 nTPM
ReferencesPubMed · IEDB
Publications for MAPK3 from three distinct lines of evidence, kept separate because they answer different questions: whether antibodies are directed at the protein, whether a B-cell epitope has been mapped on it, and whether a T-cell epitope has. Each is labelled with its source.
Reference: AutoantibodyPubMed
1 publication
Sources: PubMed — antigen-level antibody evidence from a custom retrieval. Records matching a controlled set of autoantibody terms (the MeSH descriptors Autoantibodies and Autoantigens, with title and abstract term variants) were obtained through NCBI E-utilities, and their titles and abstracts parsed for constructions that direct an antibody at a named protein rather than for co-occurrence. Captured names were resolved against UniProt nomenclature and each antigen adjudicated individually against the source text. Bibliographic records from PubMed and MeSH, U.S. National Library of Medicine; citation metrics from NIH iCite (Hutchins et al., PLoS Biology 2016). Titles link to PubMed; abstracts are not reproduced here. The NLM does not endorse this analysis.
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 0.61
- gnomAD pLI
- 0.04
- gnomAD missense Z
- 1.74
- DepMap mean gene effect
- -0.13
- DepMap dependency class
- selective
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 5% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
- apoptotic process
- Bergmann glial cell differentiation
- BMP signaling pathway
- cardiac neural crest cell development involved in heart development
- cartilage development
- caveolin-mediated endocytosis
- cell surface receptor signaling pathway
- cellular response to amino acid starvation
- cellular response to mechanical stimulus
- cellular response to tumor necrosis factor
- DNA-templated transcription
- epidermal growth factor receptor signaling pathway
- ERBB2-ERBB3 signaling pathway
- ERK1 and ERK2 cascade
- face development
- insulin receptor signaling pathway
- insulin-like growth factor receptor signaling pathway
- interleukin-1-mediated signaling pathway
- interleukin-34-mediated signaling pathway
- intracellular signal transduction
- lipopolysaccharide-mediated signaling pathway
- lung morphogenesis
- MAPK cascade
- modulation of chemical synaptic transmission
- myelination
- negative regulation of cholesterol efflux
- negative regulation of T cell mediated immune response to tumor cell
- negative regulation of TORC1 signaling
- outer ear morphogenesis
- peptidyl-tyrosine autophosphorylation
- phosphorylation
- positive regulation of cyclase activity
- positive regulation of ERK1 and ERK2 cascade
- positive regulation of macrophage chemotaxis
- positive regulation of macrophage proliferation
- positive regulation of neuroinflammatory response
- positive regulation of telomere maintenance
- positive regulation of transcription by RNA polymerase II
- positive regulation of xenophagy
- protein phosphorylation
- regulation of cellular pH
- regulation of cytoskeleton organization
- regulation of early endosome to late endosome transport
- regulation of Golgi inheritance
- regulation of ossification
- regulation of stress-activated MAPK cascade
- response to epidermal growth factor
- response to exogenous dsRNA
- Schwann cell development
- sensory perception of pain
- signal transduction in response to DNA damage
- stress-activated MAPK cascade
- thymus development
- thyroid gland development
- trachea formation
- xenophagy
Molecular functions
- ATP binding
- DNA-binding transcription factor binding
- identical protein binding
- MAP kinase activity
- phosphatase binding
- phosphotyrosine residue binding
- protein serine kinase activity
- protein serine/threonine kinase activity
Cellular components
Protein domainsUniProt · Pfam · InterPro
KeywordsUniProt
InteractionsUniProt · HPA
Protein binding partners of MAPK3 in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads MAPK3 as an antibody target. Whether an autoantibody or antibody against MAPK3 could matter depends on whether native MAPK3 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
MAPK3 is annotated at the cell surface, where native MAPK3 is exposed to circulating antibodies and is a prime autoantibody target that could block, deplete, or overstimulate it.
Annotation status
The present source text does not explicitly label MAPK3 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...